The Department of Health-Center for Health Development (DOH-CHD) Caraga introduced the ABCDE to prevent the transmission of ...

A drug currently used to treat certain HIV infections has also, on Wednesday, received approval from the US Food and Drug ...

Pharmaceutical company Gilead Sciences announced Wednesday the Food and Drug Administration (FDA) has approved its six-month, ...

Gilead Sciences, Inc. (Nasdaq: GILD) today announced that the U.S. Food and Drug Administration (FDA) has approved Yeztugo® ...

The US Food and Drug Administration (FDA) has approved a medicine that would reduce the risk of acquiring HIV in adult ...

The FDA approved lenacapavir (Yeztugo) as pre-exposure prophylaxis (PrEP) to reduce the risk of sexually acquired HIV-1 in at ...

Jio Financial Services (JFSL) has acquired the entire 17.8% stake held by the State Bank of India in Jio Payments Bank. This ...

The dueling litigation is the latest in a string of legal battles that Priscilla and the Presley heirs have been involved in ...

Managed Healthcare Executive gives C-suite executives in health plans and provider organizations news and strategies for ...

Gilead Sciences, Inc., a biopharmaceutical company, has received approval from the U.S. Food and Drug Administration (FDA) ...

Researchers at the University of Liverpool have indicated that this HIV prevention drug could be manufactured and rolled out at around $40 per person per year.

Funds will be used to create a support network for providers of HIV/AIDS care Holy Cross Health has received a three-year grant from ViiV Positive Action Network to develop a support network for peers ...